No abstract available
MeSH terms
-
Aged
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / adverse effects*
-
Aptamers, Nucleotide / administration & dosage
-
Aptamers, Nucleotide / adverse effects*
-
Exudates and Transudates
-
Humans
-
Injections
-
Macular Degeneration / complications
-
Macular Degeneration / drug therapy*
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / immunology*
-
Vitreous Body
Substances
-
Angiogenesis Inhibitors
-
Aptamers, Nucleotide
-
Vascular Endothelial Growth Factor A
-
pegaptanib